Suzanne C. Danhauer

Suzanne C. Danhauer

Auto-generated profile, based on publicly available information

Suzanne C. Danhauer

Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, North Carolina, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2013 in Psycho-Oncology
Verified
Journal Article
Closed access
PDF file
SDSuzanne C. Danhauer
Suzanne C. Danhauer
LCL. Douglas Case
L. Douglas Case
RTRichard Tedeschi
Richard Tedeschi
GRGreg Russell
Greg Russell
TVTanya Vishnevsky
Tanya Vishnevsky
NANancy E. Avis
Nancy E. Avis

1 April 2019 in Cancer
Verified
Journal Article
Open access
PDF file
SDSuzanne C. Danhauer
Suzanne C. Danhauer
EAElizabeth L. Addington
Elizabeth L. Addington
LCLorenzo Cohen
Lorenzo Cohen
SSStephanie J. Sohl
Stephanie J. Sohl
MPMarieke Van Puymbroeck
Marieke Van Puymbroeck
S.Nicole Culos-ReedS.Nicole Culos-Reed
S.Nicole Culos-Reed
Because yoga is increasingly recognized as a complementary approach to cancer symptom management, patients/survivors and providers need to understand its potential benefits and limitations both during and after treatment. The authors reviewed randomized controlled trials (RCTs) of yoga conducted at these points in the cancer continuum (N = 29; n = 13 during treatment, n = 12 post‐treatment, and n = 4 with mixed samples). Findings both during and after treatment demonstrated the efficacy of yoga to improve overall quality of life (QOL), with improvement in subdomains of QOL varying across studies. Fatigue was the most commonly measured outcome, and most RCTs conducted during or after cancer treatment reported improvements in fatigue. Results also suggested that yoga can improve stress/distress during treatment and post‐treatment disturbances in sleep and cognition. Several RCTs provided evidence that yoga may improve biomarkers of stress, inflammation, and immune function. Outcomes with limited or mixed findings (eg, anxiety, depression, pain, cancer‐specific symptoms, such as lymphedema) and positive psychological outcomes (such as benefit‐finding and life satisfaction) warrant further study. Important future directions for yoga research in oncology include: enrolling participants with cancer types other than breast, standardizing self‐report assessments, increasing the use of active control groups and objective measures, and addressing the heterogeneity of yoga interventions, which vary in type, key components (movement, meditation, breathing), dose, and delivery mode.

28 June 2012 in Journal of Clinical Psychology in Medical Settings
Verified
Journal Article
Closed access
PDF file
SDSuzanne C. Danhauer
Suzanne C. Danhauer
GRGregory B. Russell
Gregory B. Russell
RTRichard G. Tedeschi
Richard G. Tedeschi
MJMichelle T. Jesse
Michelle T. Jesse
TVTanya Vishnevsky
Tanya Vishnevsky
BPBayard L. Powell
Bayard L. Powell

7 January 2017 in Supportive Care in Cancer
Verified
Journal Article
Closed access
PDF file
SDSuzanne C. Danhauer
Suzanne C. Danhauer
EAElizabeth L. Addington
Elizabeth L. Addington
SSStephanie J. Sohl
Stephanie J. Sohl
ACAlejandro Chaoul
Alejandro Chaoul
LCLorenzo Cohen
Lorenzo Cohen

19 March 2015 in Annals of Behavioral Medicine
Verified
Journal Article
Open access
PDF file
SDSuzanne C. Danhauer
Suzanne C. Danhauer
GRGreg Russell
Greg Russell
LCL. Douglas Case
L. Douglas Case
SSStephanie J. Sohl
Stephanie J. Sohl
RTRichard G. Tedeschi
Richard G. Tedeschi
NANancy E. Avis
Nancy E. Avis
Background. Cancer survivors may experience posttraumatic growth (PTG), positive psychological changes resulting from highly stressful events; however,

14 December 2012 in Aging, Neuropsychology, and Cognition
Verified
Journal Article
Closed access
SDSuzanne C. Danhauer
Suzanne C. Danhauer
CLClaudine Legault
Claudine Legault
HBHanna Bandos
Hanna Bandos
KKKelley Kidwell
Kelley Kidwell
JCJoseph Costantino
Joseph Costantino
SSSally Shumaker
Sally Shumaker
Objectives: This study examined the relationship between positive and negative affect, depressive symptoms, and cognitive performance. Methods: The sample consisted of 1479 non-demented, postmenopausal women (mean age = 67 years) at increased risk of breast cancer enrolled in the National Surgical Adjuvant Breast and Bowel Project’s Study of Tamoxifen and Raloxifene. At each annual visit, women completed a standardized neuropsychological battery and self-report measures of affect and depression. Data from three visits were used in linear mixed models for repeated measures using likelihood ratio tests. Separate analyses were performed to relate positive/negative affect and depression to each cognitive measure. Results: Higher positive affect was associated with better letter fluency (p = .006) and category fluency (p < .0001). Higher negative affect was associated with worse global cognitive function (p < .0001), verbal memory (CVLT List B; p = .002), and spatial ability (p < .0001). Depressive symptoms were negatively associated with verbal knowledge (p = .004), figural memory (p < .0001), and verbal memory (p’s ≤ .0001). Discussion: Findings are consistent with some prior research demonstrating a link between positive affect and increased verbal fluency and between depressive symptoms and decreased memory. The most novel finding shows that negative affect is related to decreased global cognition and visuospatial ability. Overall, this research in a large, longitudinal sample supports the notion that positive affect is related to increases and negative affect to decreases in performance on distinct cognitive measures.